{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:44:03Z","timestamp":1767008643291,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jgar.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T12:37:55Z","timestamp":1551271075000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran"],"prefix":"10.1016","volume":"19","author":[{"given":"Mojtaba","family":"Alimolaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid-Reza","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Ezatkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Shamsaddini Bafti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadegh","family":"Afzali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.02.013_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.anaerobe.2016.06.008","article-title":"Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O\u2019Toole 1935) Pr\u00e9vot 1938","volume":"40","author":"Lawson","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.jgar.2019.02.013_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","article-title":"Clostridium difficile-associated diarrhea in adults","volume":"171","author":"Poutanen","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.jgar.2019.02.013_bib0015","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/archinte.162.19.2177","article-title":"The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea","volume":"162","author":"Hurley","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jgar.2019.02.013_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jinf.2012.10.019","article-title":"Clostridium difficile: a European perspective","volume":"66","author":"Jones","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2019.02.013_bib0025","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2014more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2019.02.013_bib0030","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2019.02.013_bib0035","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0040","doi-asserted-by":"crossref","first-page":"18942","DOI":"10.2807\/ese.13.31.18942-en","article-title":"Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008","volume":"13","author":"Kuijper","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2019.02.013_bib0045","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","article-title":"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe","volume":"366","author":"Warny","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2019.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","author":"Bignardi","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2019.02.013_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajic.2006.12.006","article-title":"Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities","volume":"35","author":"Dubberke","year":"2007","journal-title":"Am J Infect Control"},{"issue":"Suppl 5","key":"10.1016\/j.jgar.2019.02.013_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2008.01992.x","article-title":"Infection control measures to limit the spread of Clostridium difficile","volume":"14","author":"Vonberg","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.02.013_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2012.02.004","article-title":"Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection","volume":"81","author":"Wiegand","year":"2012","journal-title":"J Hosp Infect"},{"issue":"Suppl 2","key":"10.1016\/j.jgar.2019.02.013_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.02.013_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2007.03.009","article-title":"Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile","volume":"59","author":"Schmidt","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0080","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jac\/dkn313","article-title":"Emergence of reduced susceptibility to metronidazole in Clostridium difficile","volume":"62","author":"Baines","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"248","key":"10.1016\/j.jgar.2019.02.013_bib0085","first-page":"e9","article-title":"Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes","volume":"21","author":"Freeman","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.02.013_bib0090","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pelaez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.013_bib0095","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/AAC.00220-12","article-title":"Antimicrobial-resistant strains of Clostridium difficile from North America","volume":"56","author":"Tenover","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.02.013_bib0100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijantimicag.2012.08.011","article-title":"Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium difficile from a Chinese tertiary hospital","volume":"41","author":"Dong","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.02.013_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anaerobe.2014.07.003","article-title":"Comparison of culture based methods for the isolation of Clostridium difficile from stool samples in a research setting","volume":"28","author":"Lister","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.jgar.2019.02.013_bib0115","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/jmm.0.056515-0","article-title":"Isolation of Clostridium difficile from faecal specimens\u2014a comparison of chromID C. difficile agar and cycloserine\u2013cefoxitin\u2013fructose agar","volume":"62","author":"Carson","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2019.02.013_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.micpath.2016.05.018","article-title":"Clostridium difficile infection: early history, diagnosis and molecular strain typing methods","volume":"97","author":"Rodriguez","year":"2016","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jgar.2019.02.013_bib0125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-008-0564-9","article-title":"Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006\u20132007","volume":"27","author":"Fenner","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0130","series-title":"CLSI document M11-A7","article-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard\u2014seventh edition","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2007"},{"key":"10.1016\/j.jgar.2019.02.013_bib0135","series-title":"CLSI document M100-S22.","article-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"year":"2017","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","key":"10.1016\/j.jgar.2019.02.013_bib0140"},{"year":"2013","series-title":"Recommandations 2013","author":"Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (CA-SFM)","key":"10.1016\/j.jgar.2019.02.013_bib0145"},{"key":"10.1016\/j.jgar.2019.02.013_bib0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1469-0691.2012.03907.x","article-title":"Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut\u2010off values and disk diffusion correlates","volume":"18","author":"Erikstrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.02.013_bib0155","first-page":"739","article-title":"Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis","volume":"92","author":"Fekety","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jgar.2019.02.013_bib0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/S0074-02762003000400003","article-title":"Prevalence of Clostridium spp. and Clostridium difficile in children with acute diarrhea in Sao Paulo city, Brazil","volume":"98","author":"Ferreira","year":"2003","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jgar.2019.02.013_bib0165","first-page":"320","article-title":"The incidence of nosocomial toxigenic Clostridium difficile associated diarrhea in Tehran tertiary medical centers","volume":"48","author":"Sadeghifard","year":"2010","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.jgar.2019.02.013_bib0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00145303","article-title":"Clostridium difficile acquisition rate and its role in nosocomial diarrhoea at a university hospital in Turkey","volume":"12","author":"S\u00f6yletir","year":"1996","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jgar.2019.02.013_bib0175","first-page":"210","article-title":"Frequency of Clostridium difficile among patients with gastrointestinal complaints","volume":"4","author":"Nazemalhosseini-Mojarad","year":"2011","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.jgar.2019.02.013_bib0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrgastro.2010.190","article-title":"Clostridium difficile infection: epidemiology, risk factors and management","volume":"8","author":"Ananthakrishnan","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jgar.2019.02.013_bib0185","first-page":"67","article-title":"Prevalence of Clostridium difficile-associated diarrhea in hospitalized patients with nosocomial diarrhea","volume":"34","author":"Sadeghifard","year":"2005","journal-title":"Iran J Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.jgar.2019.02.013_bib0190","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0195","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/jam.14035","article-title":"Highly antibiotic\u2010resistant Clostridium difficile isolates from Iranian patients","volume":"125","author":"Baghani","year":"2018","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jgar.2019.02.013_bib0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jgar.2019.02.013_bib0205","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","article-title":"Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole","volume":"40","author":"Musher","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0210","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.02.013_bib0215","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5812\/ircmj.5189","article-title":"Antimicrobial susceptibility of Clostridium difficile clinical isolates in Iran","volume":"15","author":"Goudarzi","year":"2013","journal-title":"Iranian Red Crescent Med J"},{"key":"10.1016\/j.jgar.2019.02.013_bib0220","first-page":"916826","article-title":"Clostridium difficile infection: epidemiology, pathogenesis, risk factors, and therapeutic options","volume":"2014","author":"Goudarzi","year":"2014","journal-title":"Scientifica (Cairo)"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:53:51Z","timestamp":1761990831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":44,"alternative-id":["S2213716519300530"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.02.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}